Detection of primary melanoma in individuals at extreme high risk: A prospective 5-year follow-up study

JAMA Dermatology

Volumn 150, Issue 8, 2014, Pages 819-827

  Moloney, Fergal J ^a,b,c,d   Guitera, Pascale ^a,b,c   Coates, Elliot ^a,b,c   Haass, Nikolas K ^a,b,c,e   Ho, Kenneth ^a,b,c   Khoury, Ritta ^b,c   O'Connell, Rachel L ^a   Raudonikis, Leo ^f   Schmid, Helen ^a,g   Mann, Graham J ^a,g   Menzies, Scott W ^a,b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c SYDNEY CANCER CENTRE   (Australia)

^d MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f Raudonikis Database Services   (Australia)

^g MELANOMA INSTITUTE AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ADULT; AGED; ARTICLE; AUSTRALIA; BASAL CELL CARCINOMA; BRESLOW THICKNESS; CANCER CENTER; CANCER DIAGNOSIS; CANCER INCIDENCE; CAUSE OF DEATH; COHORT ANALYSIS; CUTANEOUS PARAMETERS; DYSPLASTIC NEVUS; EPILUMINESCENCE MICROSCOPY; FAMILY HISTORY; FEMALE; FIRST DEGREE RELATIVE; FOLLOW UP; GENE MUTATION; HIGH RISK PATIENT; HUMAN; KERATOACANTHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MELANOMA; METASTATIC MELANOMA; OBSERVATIONAL STUDY; PHYSICAL EXAMINATION; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; SECOND DEGREE RELATIVE; SEQUENTIAL DIGITAL DERMOSCOPY IMAGING; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TOTAL BODY PHOTOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; DERMOSCOPY; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MELANOMA; MIDDLE AGED; PHOTOGRAPHY; PHYSICAL EXAMINATION; PROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS; TIME FACTORS; YOUNG ADULT;

EID: 84906739607     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2014.514     Document Type: Article

References (33)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-2917.
2. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma. I. common and atypical naevi. Eur J Cancer. 2005;41(1):28-44. (Pubitemid 40029657)
3. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma. III. family history, actinic damage and phenotypic factors. Eur J Cancer. 2005;41(14):2040-2059. (Pubitemid 41337946)
4. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma. II. sun exposure. Eur J Cancer. 2005;41(1):45-60. (Pubitemid 40029658)
5. Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand. Sydney, Australia: Cancer Council Australia and Australian Cancer Network; and Wellington, New Zealand: Ministry of Health, New Zealand; 2008.
6. Salerni G, Carrera C, Lovatto L, et al. Characterization of 1152 lesions excised over 10 years using total-body photography and digital dermatoscopy in the surveillance of patients at high risk for melanoma. J Am Acad Dermatol. 2012;67(5):836-845.
7. Haenssle HA, Korpas B, Hansen-Hagge C, et al. Seven-point checklist for dermatoscopy: performance during 10 years of prospective surveillance of patients at increased melanoma risk. J Am Acad Dermatol. 2010;62(5):785-793.
8. Wang SQ, Kopf AW, Koenig K, Polsky D, Nudel K, Bart RS. Detection of melanomas in patients followed up with total cutaneous examinations, total cutaneous photography, and dermoscopy. J Am Acad Dermatol. 2004;50(1):15-20. (Pubitemid 38095645)
9. Vestergaard ME, Macaskill P, Holt PE, Menzies SW. Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting. Br J Dermatol. 2008;159(3):669-676.
10. Menzies SW, Stevenson ML, Altamura D, Byth K. Variables predicting change in benign melanocytic nevi undergoing short-term dermoscopic imaging. Arch Dermatol. 2011;147(6):655-659.
11. Altamura D, Avramidis M, Menzies SW. Assessment of the optimal interval for and sensitivity of short-term sequential digital dermoscopy monitoring for the diagnosis of melanoma. Arch Dermatol. 2008;144(4):502-506. (Pubitemid 351581107)
12. Tromme I, Sacré L, Hammouch F, et al; DEPIMELA study group. Availability of digital dermoscopy in daily practice dramatically reduces the number of excised melanocytic lesions: results from an observational study. Br J Dermatol. 2012;167(4):778-786.
13. Salerni G, Carrera C, Lovatto L, et al. Benefits of total body photography and digital dermatoscopy ("two-step method of digital follow-up") in the early diagnosis of melanoma in patients at high risk for melanoma. J Am Acad Dermatol. 2012;67(1):e17-e27.
14. Menzies SW, Crotty K, Ingvar C, McCarthy W. Dermoscopy, an Atlas. 3rd ed. Sydney, Australia: McGraw-Hill; 2009.
15. Goldstein AM, Chan M, Harland M, et al Lund Melanoma Study Group; Melanoma Genetics Consortium (GenoMEL). Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet. 2007;44(2):99-106.
16. Menzies SW, Gutenev A, Avramidis M, Batrac A, McCarthy WH. Short-term digital surface microscopic monitoring of atypical or changing melanocytic lesions. Arch Dermatol. 2001;137(12):1583-1589. (Pubitemid 34000906)
17. Kittler H, Pehamberger H, Wolff K, Binder M. Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi. J Am Acad Dermatol. 2000;43(3):467-476. (Pubitemid 30666738)
18. Kittler H, Guitera P, Riedl E, et al. Identification of clinically featureless incipient melanoma using sequential dermoscopy imaging. Arch Dermatol. 2006;142(9):1113-1119. (Pubitemid 44414394)
19. Halpern AC. Total body skin imaging as an aid to melanoma detection. Semin Cutan Med Surg. 2003;22(1):2-8. (Pubitemid 36547460)
20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
21. Diggle P, Liang KY, Zeger SL. Analysis of Longitudinal Data. Oxford, England: Clarendon Press; 1994.
22. Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials. 1996;17(4):343-346. (Pubitemid 26342716)
23. Bradford PT, Freedman DM, Goldstein AM, Tucker MA. Increased risk of second primary cancers after a diagnosis of melanoma. Arch Dermatol. 2010;146(3):265-272.
24. Ferrone CR, Ben Porat L, Panageas KS, et al. Clinicopathological features of and risk factors for multiple primary melanomas. JAMA. 2005;294(13):1647- 1654. (Pubitemid 41407357)
25. Hemminki K, Zhang H, Czene K. Familial and attributable risks in cutaneous melanoma: effects of proband and age. J Invest Dermatol. 2003;120(2):217-223. (Pubitemid 36513070)
26. Malvehy J, Puig S. Follow-up of melanocytic skin lesions with digital total-body photography and digital dermoscopy: a two-stepmethod. Clin Dermatol. 2002;20(3):297-304. (Pubitemid 34628901)
27. Doubrovsky A, Menzies SW. Enhanced survival in patients with multiple primary melanoma. Arch Dermatol. 2003;139(8):1013-1018. (Pubitemid 36994826)
28. Kang S, Barnhill RL, Mihm MC Jr, Sober AJ. Multiple primary cutaneous melanomas. Cancer. 1992;70(7):1911-1916.
29. Slingluff CL Jr, Vollmer RT, Seigler HF. Multiple primary melanoma: incidence and risk factors in 283 patients. Surgery. 1993;113(3):330-339. (Pubitemid 23082254)
30. Youl PH, Youlden DR, Baade PD. Changes in the site distribution of common melanoma subtypes in Queensland, Australia over time: implications for public health campaigns. Br J Dermatol. 2013;168(1):136-144.
31. Wharton JM, Carlson JA, Mihm MC Jr. Desmoplastic malignant melanoma: diagnosis of early clinical lesions. Hum Pathol. 1999;30(5):537-542. (Pubitemid 29218047)
32. Menzies SW, Moloney FJ, Byth K, et al. Dermoscopic evaluation of nodular melanoma. JAMA Dermatol. 2013;149(6):699-709.
33. Rice ZP, Weiss FJ, DeLong LK, Curiel-Lewandrowski C, Chen SC. Utilization and rationale for the implementation of total body (digital) photography as an adjunct screening measure for melanoma. Melanoma Res. 2010;20(5):417-421.